Biotech Capital

BTC Health (formerly Biotech Capital Limited) is an Australian-listed healthcare investment and distribution company (ASX: BTC). The company operates through a group of wholly-owned subsidiaries, including BTC Speciality Health, BTC Pharma, and BTC Cardio, which focus on the commercialization of medical devices, consumables, and specialty pharmaceuticals in Australia and New Zealand. BTC Health transitioned from a Pooled Development Fund to an active operating entity, specializing in high-growth therapeutic areas such as cardiology, respiratory care, and critical care. Its strategy involves acquiring or in-licensing innovative healthcare products from international partners and leveraging its established sales and distribution network to drive market penetration. The company is led by an experienced management team with a track record in the life sciences sector.